TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Unimedic Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
335,088
|
381,109
|
315,501 |
| Financial expenses |
6,879
|
3,798
|
2,131 |
| Earnings before taxes |
29,599
|
73,166
|
67,543 |
| EBITDA |
35,109
|
82,828
|
76,665 |
| Total assets |
197,188
|
199,418
|
198,791 |
| Current assets |
185,119
|
184,398
|
176,807 |
| Current liabilities |
36,382
|
57,505
|
85,020 |
| Equity capital |
93,986
|
75,687
|
36,870 |
| - share capital |
200
|
200
|
200 |
| Employees (average) |
31
|
27
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.7%
|
38.0%
|
18.5% |
| Turnover per employee |
10,809
|
14,115
|
11,685 |
| Profit as a percentage of turnover |
8.8%
|
19.2%
|
21.4% |
| Return on assets (ROA) |
18.5%
|
38.6%
|
35.0% |
| Current ratio |
508.8%
|
320.7%
|
208.0% |
| Return on equity (ROE) |
31.5%
|
96.7%
|
183.2% |
| Change turnover |
-46,021
|
65,608
|
67,253 |
| Change turnover % |
-12%
|
21%
|
27% |
| Chg. No. of employees |
4
|
0
|
2 |
| Chg. No. of employees % |
15%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.